View Future GrowthSrigee DLM 과거 순이익 실적과거 기준 점검 3/6Srigee DLM은 연평균 27.7%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 6.7% 증가했습니다. 매출은 연평균 10.8%의 비율로 감소했습니다. Srigee DLM의 자기자본이익률은 11.1%이고 순이익률은 7.2%입니다.핵심 정보27.72%순이익 성장률24.76%주당순이익(EPS) 성장률Chemicals 산업 성장률17.68%매출 성장률-10.84%자기자본이익률11.11%순이익률7.21%다음 순이익 업데이트27 May 2026최근 과거 실적 업데이트공시 • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.공시 • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.공시 • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025모든 업데이트 보기Recent updates공시 • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹64.00, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 20x in the Chemicals industry in India.New Risk • Nov 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$10m (₹710.6m market cap, or US$7.95m).Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹87.45, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India.Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.공시 • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025공시 • Sep 30Srigee Dlm Limited Appoints Indu Shekhar Tripathi as Non-Executive Independent DirectorSrigee DLM Limited in the 20th annual general meeting held on September 30, 2025 announced the appointment of Mr. Indu Shekhar Tripathi (DIN: 00654167) as y of the company.New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹861.1m (US$9.71m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). High level of non-cash earnings (38% accrual ratio). Market cap is less than US$10m (₹861.1m market cap, or US$9.71m).Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.공시 • Sep 08Srigee DLM Limited, Annual General Meeting, Sep 30, 2025Srigee DLM Limited, Annual General Meeting, Sep 30, 2025, at 10:00 Indian Standard Time. Location: plot 39 and 40 udyog vihar, extension, ecotech ii, greater, noida, uttar pradesh, india, 201306, greater noida IndiaValuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹170, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹317, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 29x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹319, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 28x in the Chemicals industry in India.New Risk • Jun 03New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 36% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.44b market cap, or US$16.8m).Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.공시 • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025Board Change • May 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Indu Tripathi was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Srigee DLM가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BSE:544399 매출, 비용 및 순이익 (INR Millions)날짜매출순이익일반관리비연구개발비30 Sep 255604030030 Jun 256364526031 Mar 257125022031 Mar 245442918031 Mar 234712822031 Mar 223301126031 Mar 212841120031 Mar 2026710110양질의 수익: 544399는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 544399의 현재 순 이익률 (7.2%)은 지난해 (6.3%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 544399의 수익은 지난 5년 동안 연평균 27.7%로 크게 증가했습니다.성장 가속화: 지난 1년간 544399 의 수익 증가율(1.9%)은 5년 평균(연간 27.7%)보다 낮습니다.수익 대 산업: 544399의 지난 1년 수익 증가율(1.9%)은 Chemicals 업계 평균(10.4%)을 능가하지 못했습니다.자기자본이익률높은 ROE: 544399의 자본 수익률(11.1%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 23:44종가2026/05/22 00:00수익2025/09/30연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Srigee DLM Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026
Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.
공시 • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025
Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.
Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.
공시 • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025
공시 • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹64.00, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 20x in the Chemicals industry in India.
New Risk • Nov 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$10m (₹710.6m market cap, or US$7.95m).
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹87.45, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India.
Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.
공시 • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025
공시 • Sep 30Srigee Dlm Limited Appoints Indu Shekhar Tripathi as Non-Executive Independent DirectorSrigee DLM Limited in the 20th annual general meeting held on September 30, 2025 announced the appointment of Mr. Indu Shekhar Tripathi (DIN: 00654167) as y of the company.
New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹861.1m (US$9.71m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). High level of non-cash earnings (38% accrual ratio). Market cap is less than US$10m (₹861.1m market cap, or US$9.71m).
Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.
공시 • Sep 08Srigee DLM Limited, Annual General Meeting, Sep 30, 2025Srigee DLM Limited, Annual General Meeting, Sep 30, 2025, at 10:00 Indian Standard Time. Location: plot 39 and 40 udyog vihar, extension, ecotech ii, greater, noida, uttar pradesh, india, 201306, greater noida India
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹170, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹317, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 29x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹319, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 28x in the Chemicals industry in India.
New Risk • Jun 03New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 36% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.44b market cap, or US$16.8m).
Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.
공시 • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025
Board Change • May 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Indu Tripathi was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.